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RESEARCH ARTICLE
Clinical Scores for Dyspnoea Severity in
Children: A Prospective Validation Study
Hendriekje Eggink1,2, Paul Brand1,2, Roelien Reimink1, Jolita Bekhof1*





In acute dyspnoeic children, assessment of dyspnoea severity and treatment response is
frequently based on clinical dyspnoea scores. Our study aim was to validate five commonly
used paediatric dyspnoea scores.
Methods
Fifty children aged 0–8 years with acute dyspnoea were clinically assessed before and after
bronchodilator treatment, a subset of 27 children were videotaped and assessed twice by
nine observers. The observers scored clinical signs necessary to calculate the Asthma
Score (AS), Asthma Severity Score (ASS), Clinical Asthma Evaluation Score 2 (CAES-2),
Pediatric Respiratory Assessment Measure (PRAM) and respiratory rate, accessory muscle
use, decreased breath sounds (RAD).
Results
A total of 1120 observations were used to assess fourteen measurement properties within
domains of validity, reliability and utility. All five dyspnoea scores showed overall poor results,
scoring insufficiently onmore than half of the quality criteria for measurement properties. The
AS and PRAMwere the most valid with good values on six and moderate values on three
properties. Poor results were mainly due to insufficient measurement properties in the validity
and reliability domains whereas utility properties were moderate to good in all scores.
Conclusion
This study shows that commonly used dyspnoea scores show insufficient validity and reli-
ability to allow for clinical use without caution.
Introduction
Acute dyspnoea is an important reason for paediatric emergencies and hospital admissions [1].
Assessment of dyspnoea severity and treatment response is essential for therapeutic
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management. Evaluation of dyspnoea severity in children primarily relies on clinical evalua-
tion, because pulmonary function tests are unreliable and infeasible in acutely dyspnoeic chil-
dren [2]. This clinical evaluation usually involves a combination of clinical signs, as there is
there is no single clinical sign that sufficiently correlates with the degree of dyspnoea or airway
narrowing [3–6]. For this purpose, a range of dyspnoea scores, comprising a combination of
clinical features and signs, have been developed. Although these are being widely used both in
clinical practice and in research, evidence on their measurement properties is limited [7–9].
For instance, adequate information on evaluative quality (responsiveness after treatment) is
lacking in all existing scores, limiting their use as evaluative instrument in clinical practice or
research. Although the lack of sufficient information from validation studies does not necessar-
ily disqualify existing scores to reliably measure dyspnoea, it does emphasize the need for fur-
ther validation [7–9].
The aim of this study was to prospectively assess validity and reliability of five commonly
used paediatric dyspnoea scores [7–9]: the Asthma Score (AS) [5]; Asthma Severity Score
(ASS) [2], Clinical Asthma Evaluation Score 2 (CAES-2) [3], Pediatric Respiratory Assessment
Measure (PRAM) [10–11] and the respiratory rate, accessory muscle use, decreased breath
sounds (RAD) [12].
Methods
Study population and design
We prospectively recruited fifty children aged 0–8 years, presenting with acute dyspnoea and
wheeze to the emergency department of Isala, a large teaching hospital in Zwolle, the Nether-
lands. All children were assessed before and 30 minutes after treatment with a standard dose of
nebulized salbutamol (2.5 mg for patients aged< 4 years and 5 mg for ages 4 years). Only
children treated with nebulized salbutamol were included in the study. The emergency depart-
ment nurse counted the respiratory rate for 1 minute and recorded heart rate and transdermal
oxygen saturation by pulse oximetry. If oxygen saturation was<93% or when the child’s dys-
pnoea was considered to be severe, supplemental oxygen was provided through nasal prongs.
Respiratory and heart rate were classified using age-equivalent percentile categories [13]. After
bronchodilator administration, the attending clinician rated whether the patient showed
improvement, slight improvement, no change or deterioration. In addition, after parental
informed consent was obtained to videotape the head and chest of the children before and 30
minutes after bronchodilator administration. The heart rate and transdermal oxygen satura-
tion were visible on the pulse oximetry during the whole recording. Video recording took place
in a single-bed room to prevent disturbing noises and ensure the assessors could hear the
wheezing, which was confirmed during evaluations by the assessors.
Written parental informed consent was obtained on behalf of the children to videotape the
children. The study was approved by the hospital’s medical research and ethics committee
Medical Ethical Committee Isala, Zwolle (09.0536n).
Video assessment
Five paediatricians and four paediatric nurses, each with at least five years of experience in pae-
diatrics, rated the videos. Observers were blinded from clinical information and the timing of
the video (before or after bronchodilator treatment). They assessed all necessary items to calcu-
late the five dyspnoea scores: respiratory rate, wheeze, prolonged expiratory phase, retractions
(subcostal, intercostal, jugular, supraclavicular), nasal flaring and mental status. Except for
respiratory rate, these clinical signs were rated according to a scale ranging from none, mild,
moderate to severe. Finally, an overall dyspnoea severity score on a Likert-scale from 0 (no
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Interquartile range; MIC, Minimal important change;
PRAM, Pediatric Respiratory assessment measure;
RAD, Respiratory rate, accessory muscle use,
decreased breath sounds; SD, Standard deviation;
SDC, Smallest detectable change; SEM, Standard
error of measurements.
dyspnoea) to 10 (severe dyspnoea defined as respiratory insufficiency) was given. Observers
rated all videos twice with an interval of at least two weeks. Participating paediatricians and
paediatric nurses gave verbal informed consent.
Dyspnoea scores
We assessed the dyspnoea scores AS [5], ASS [2], CAES-2 [3], PRAM [10, 11] and RAD [12]
(S1 File) because these showed the best measurement properties in a systematic review that we
performed earlier on all paediatric dyspnoea scores reported in the literature [9]. Moreover,
these five scores were considered suitable for the entire paediatric age span and involved no dif-
ficult auscultation skills for the assessment. The range of scores were: AS (5–15), ASS (0–9),
CAES-2 (0–8), PRAM (0–12) and RAD (0–3).
We purposely left out auscultatory findings, to reflect daily clinical practice in which health-
care professionals assessing the child are not always trained in pulmonary auscultation, and for
reasons of feasibility (having an acutely dyspnoeic child auscultated by nine independent asses-
sors was considered infeasible and excessively distressing to the child).
Statistical analysis
The five dyspnoea scores were evaluated according to the Consensus-based Standards for the
selection of health Measurement Instruments initiative (COSMIN) definitions of fourteen
measurement properties for validity, reliability and utility of measures (see S2 File) [14]. Six of
these properties (face and content validity, suitability, age span, ease of scoring and ausculta-
tion skills) have been described in detail previously [9], and we will explain the methodology
used for the other eight measurement properties (construct and criterion-concurrent validity,
measurement error, inter and intra-observer reliability, internal consistency, responsiveness
and floor and ceiling effects) below.[15]
Validity. To assess construct validity we formulated five pre-defined hypotheses about the
difference in scores between subgroups in our study sample, three of which referred to evalua-
tive capacity (i.e. the ability to find (small) difference in dyspnoea severity in response to treat-
ment), and two to interpretability (do more children with more severe symptoms have higher
scores?). The hypotheses we tested were: 1) Dyspnoea score improvement after treatment with
bronchodilator is larger in patients in whom the attending physician observed an improvement
after bronchodilator, compared to the stable group; 2) The response to bronchodilator treat-
ment is larger when risk factors for atopy (eczema or a positive family history) are present in
comparison to patients without risk factors; 3) Patients diagnosed with episodic wheezing or
asthma at discharge show a better response than patients diagnosed with bronchiolitis or pneu-
monia; 4) Children requiring supplemental oxygen have higher dyspnoea scores than those
without oxygen. 5) Change in dyspnoea scores is higher in children who are admitted to the
hospital in comparison to children sent home. Sufficient construct validity was reached if 75%
of the hypotheses were confirmed by an independent t-test or Mann-Whitney U test.
Concurrent validity was evaluated by comparing the total dyspnoea scores with oxygen satu-
ration, age-equivalent respiratory rate percentiles [13] and the 10-point Likert scale for dys-
pnoea severity. A Pearson or Spearman correlation coefficient of> 0.7 was considered
sufficient [14].
Reliability. Agreement was quantified by calculating the Smallest Detectable Change
(SDC) and Minimal Important Change (MIC) [16]. For a score to be of evaluative value, the
SDC must be smaller than the MIC [14]. The SDC was obtained by multiplying the standard
deviation of the change in dyspnoea score in the stable group (not importantly improved as
judged by the attending physician) by 1.96 [16, 17]. We applied the visual anchor-based MIC
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distribution to calculate the MIC for each dyspnoea score, by using two external criterions or
‘anchors’ for judgment on the degree of responsiveness to treatment [16]: 1) the clinical judg-
ment of the response to treatment by the paediatrician who assessed the child “live” at the
emergency department and 2) the difference in respiratory rate percentile before and after
administration of bronchodilator.
To assess intra- and interrater reliability, intraclass correlation coefficient (ICC) was calculated
(two way mixed models, absolute agreement and single measurements), considering an ICC of
0.70 as adequate [13]. Standard error of measurement (SEM) due to variation within observers
was calculated by: SEM = SDdifference/
p
2 [16]. The SEM due to variation between observers was
calculated by using the pooled SD of the mean scores of the different observers using the formula:
SEM = SDpooled
p




observer2 + . . ./n) [16, 17].
As the RAD score cannot be regarded a continuous variable with a range of only 4, we chose to
use weighted kappa values instead of ICC and did not calculate SEM.
Internal consistency was assessed by calculating Cronbach’s alpha [15, 16].
Responsiveness was determined calculating the area under curve (AUC) of the receiver oper-
ating characteristic curve of the improved versus stable group using the two abovementioned
anchors [14]. A value0.70 was considered appropriate.
Utility. Floor or ceiling effects were evaluated by calculating the percentage of patients with
the lowest or highest possible dyspnoea score. Floor and ceiling effects were considered ade-
quate when<15% [16].
All statistical analyses were performed using SPSS version 23.0. P values< 0.05 were consid-
ered statistically significant.
Results
Fifty patients were evaluated before and after administration of bronchodilators, some on sev-
eral occasions, resulting in 148 observations. Twenty-seven of these patients were videotaped
before and after bronchodilator treatment, assessed twice by the nine observers, accounting for
972 video ratings and thus a total of 1120 observations. Patient and clinical characteristics are
shown in Table 1.
Validity
The AS, PRAM and RAD showed adequate construct validity, defined by 75% confirmed
hypotheses (Table 2). Remarkably, hypothesis 5 showed that the change in dyspnoea scores
was rated not rated higher in patients ultimately hospitalised than in the children who were
sent home after their visit to the emergency department.
Concurrent validity showed an insufficient correlation with the oxygen saturation or respi-
ratory rate percentile for all five scores (Table 3). Correlations with the dyspnoea severity score
(Likert scale) were moderate, ranging from 0.441–0.567, and did not exceed the minimum
threshold.
Reliability
Results on agreement are presented in Table 4 (for a detailed calculation in S3 File). None of
the five dyspnoea scores showed good agreement: in all five the smallest detectable change
(SDC) was smaller than the minimal important change (MIC).
Data on intra and interrater reliability and internal consistency are presented in Table 5.
Intrarater reliability was good for the AS (ICC 0.75) and ASS (ICC 0.74) and borderline suffi-
cient for the other three scores. Only the AS showed a moderate interrater reliability (ICC
Dyspnoea Scores in Children
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0.64). Internal consistency was inadequate in all scores. For responsiveness, only the ASS
reached the threshold of an adequate AUC (Table 4).
Utility
Floor and ceiling effects were adequate in all five dyspnoea scores (Table 6)
A summary of the assessment of the 5 scores based on our results is given in Table 7.
Discussion
In this prospective study we aimed to examine external validity of five commonly used dys-
pnoea scores in children with acute dyspnoea and wheezing. To our knowledge, this is the first
study to quantitatively compare measurement properties across dyspnoea scores in dyspnoeic
children using independent ratings by nine experienced clinicians. The results show that com-
monly used dyspnoea scores in children have poor measurement properties, with insufficient
results on more than half of the quality criteria for measurement properties (7 to 9 out of 14).
The AS and PRAM were evaluated as most valid with good values on six and moderate values
on three measurement properties. The poor results were mainly due to insufficient
Table 1. Patient characteristics for total group (n = 50) and videotaped participants (n = 27).
Total (n = 50) Videotaped children (n = 27)
Demographics
Mean age in months (SD) 30.1 (25.8) 24.3 (19.9)
Male gender, n (%) 30 (60) 17 (63)
History, n (%)
Eczema 16 (32) 6 (22)
Positive family history 40 (80) 23 (85)
Previous bronchodilators 34 (68) 20 (74)
Positive effect 19/34 (56) 12 (60)
Variable/no effect 15/34 (44) 8 (40)
Clinical characteristics Pre Tx* Post Tx* Pre Tx* Post Tx*
Respiratory rate
Breaths/minute, mean (SD) 46 (15) 43 (14) 43 (15) 40 (12)
Tachypnoea¶, n (%) 35 (70) 29 (58) 20 (74) 16 (59)
Transdermal oxygen saturation
%, median (IQR) 96 (92–100) 96 (92–100) 97 (95–98) 97 (94–98)
92%, n (%) 7 (14) 4 (8) 7 (26) 4 (15)
Heart rate
Beats/min, mean (SD) 142 (20) 148 (21) 141 (18) 146 (20)
Tachycardia¶, n (%) 31 (62) 33 (66) 18 (67) 19 (70)
Disease course, n (%)
Hospitalization 34 (68) 19 (70)
Diagnosis at discharge
Acute asthma 18 (36) 7 (26)
Episodic wheeze 20 (40) 13 (48)
Bronchiolitis/pneumonia 10 (20) 6 (22)
Other 2 (4) 1 (4)
SD standard deviation; IQR interquartile range
*before or 30 minutes after treatment with bronchodilators
¶ P90 for age according to Fleming et al. [11]
doi:10.1371/journal.pone.0157724.t001
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measurement properties in the domains of validity and reliability, whilst all scores performed
moderate to well in the domain of utility.
Although assessment of validity (do the scores measure what they intend to do?) is difficult
due to the lack of a solid “gold” standard or reference value, all dyspnoea scores scored insuffi-
cient on the different aspects of validity which can be assessed in absence of a “gold” standard.
None of the composite dyspnoea scores showed good correlations with other single measures
of dyspnoea severity, including objective measures (oxygen saturation or respiratory rate) and
subjective measures (impression of dyspnoea severity judged by the attending experienced phy-
sician). These findings are consistent with earlier reports, showing poor to modest correlation
with single clinical signs or arterial oxygen saturation or airway obstruction [3–6]. The AS and
PRAM showed a significant higher, but still only slight correlation with oxygen saturation.
Table 2. Construct validity of five dyspnoea scores by testing difference between subgroups in five predefined hypotheses.
1.Physician observation Improved symptoms after
bronchodilators
no changeafter bronchodilators p-value* 95% CI
AS -0.65 ± 1.66 (212) -0.12 ± 1.58 (152) 0.002 -0.87–-0.19
ASS -0.69 ± 1.76 (154) 0.28 ± 1.60 (106) 0.002 -1.40–-0.56
CAES-2 -0.70 ± 1.52 (105) 0.08 ± 1.18 (60) 0.001 -1.20–-0.35
PRAM -0.64 ± 2.48 (146) 0.28 ± 2.21 (101) 0.003 -1.53–-0.32
RAD 0.00 IQR 1 (146) 0.00 IQR 0 (114) 0.005
2.Risk factors for asthma Positive risk factors Negative risk factors
AS -0.59 ± 1.72 (452) 0.03 ± 1.87 (75) 0.004 -1.04–-0.20
ASS -0.40 ± 1.77 (336) -0.08 ± 1.46 (64) 0.127 -0.73–0.09
CAES-2 -0.42 ± 1.43 (216) -0.34 ± 1.63 (44) 0.741 -0.56–0.40
PRAM -0.59 ± 2.28 (317) 0.13 ± 2.63 (60) 0.029 -1.37–-0.08
RAD 0.00 IQR 1 (329) 0.00 IQR 0 (60) 0.008
3.Diagnosis at discharge Asthma Bronchiolitis or pneumonia
AS -0.71 ± 1.77 (393) -0.04 ± 1.28 (95) 0.001 -0.98–-0.35
ASS -0.47 ± 1.78 (316) 0.06 ± 1.49 (53) 0.044 -1.03–-0.02
CAES-2 -0.50 ± 1.48 (213) 0.23 ± 1.45 (22) 0.028 -1.38–-0.08
PRAM -0.70 ± 2.35 (299) 0.53 ± 2.19 (51) 0.001 -1.92–-0.53
RAD 0.00 IQR 1 (296) 0.00 IQR 0 (66) 0.034
4.Oxygen supplementation Oxygen supplementation No oxygen supplementation
AS 8.76 ± 1.74 (302) 7.34 ± 1.80 (782) <0.001 1.19–1.66
ASS 4.44 ± 1.79 (257) 4.68 ± 1.87 (655) 0.085 -0.32–0.50
CAES-2 1.86 ± 1.69 (204) 1.80 ± 1.33 (492) 0.648 -0.18–0.29
PRAM 4.36 ± 2.19 (116) 2.51 ± 1.97 (331) <0.001 1.42–2.29
RAD 2.00 IQR 0 (245) 2.00 IQR 0 (644) 0.034
5.Hospital admission Admission No admission
AS -0.54 ± 1.74 (379) -0.41 ± 1.70 (148) 0.453 -0.46–0.20
ASS -0.33 ± 1.74 (301) -0.38 ± 1.70 (99) 0.797 -0.43–0.45
CAES-2 -0.38 ± 1.45 (192) -0.49 ± 1.51 (68) 0.612 -0.30–0.51
PRAM -0.61 ± 2.30 (286) -0.53 ± 2.27 (123) 0.613 -0.39–0.31
RAD 0.00 IQR 0 (548) 0.00 IQR 0 (81) 0.638
Data is presented as mean ± standard deviation or median with interquartile range (IQR); for the hypothesis 1–3 and 5, change in dyspnoea score after
bronchodilator treatment is compared between the two subgroup, and for hypothesis 4 the absolute dyspnoea score is presented. CI conﬁdence interval; AS
Asthma score (range 4–12); ASS Asthma severity score (range 0–9); CAES-2 Clinical asthma evaluation score 2 (range 0–8); PRAM Pediatric respiratory
assessment measure (range 0–12); RAD Respiratory rate, accessory muscle use, decreased breath sounds (range 0–3)
*T-test for AS, ASS, CAES-2 and PRAM; MannWhitney U for RAD
doi:10.1371/journal.pone.0157724.t002
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This is likely to be explained by the fact that SpO2 is an item in these scores, so a higher SpO2
would automatically lead to a lower score on the AS and PRAM. The validity of dyspnoea
scores may be hindered by the fact that clinical signs of dyspnoea may vary largely across dif-
ferent ages. Even within the limited age range of preschool children in our study, signs of dys-
pnoea may differ between young infants and toddlers. A score that is applicable in different
settings and across a broad age range is desirable.
The poor validity and especially the poor discriminative and evaluative properties of paedi-
atric dyspnoea scores appears to be mainly due to the large interrater variation. The discrimi-
native power of these composite scores is too low compared to the large variation in the
Table 3. Concurrent validity of five dyspnoea scores by correlating total scores with oxygen saturation, Fleming’s respiratory rate percentile and
the dyspnoea severity score.
Oxygen saturation (%) Respiratory rate percentile$ Dyspnoea severity score
96.0 ± 2.4 (88–100) 7.0 [5–8] 4.2 ± 1.8 (0–8)
Pearson’s r (n) Spearman’s ρ (n) Pearson’s r (n)
AS 7.74 ± 1.89 (4–12) -0.324** (783) 0.132** (1019) 0.567** (1019)
ASS 4.61 ± 1.85 (1–8) -0.096* (655) 0.161** (852) 0.543** (852)
CAES-2 1.82 ± 1.44 (0–8) -0.021 (492) 0.108** (648) 0.543** (648)
PRAM 3.28 ± 2.31 (0–11) -0.323** (633) 0.072* (819) 0.473** (819)
RAD# 2.0 [2–2] -0.064* (1059) 0.123** (994) 0.441** (994)
Data is presented as mean ± SD (range) or median [interquartile range]; AS Asthma score; ASS Asthma severity score; CAES-2 Clinical asthma evaluation
score 2; PRAM Pediatric respiratory assessment measure; RAD Respiratory rate, accessory muscle use, decreased breath sounds;




# Spearman’s rho correlation coefﬁcient for ordinal RAD score
doi:10.1371/journal.pone.0157724.t003
Table 4. Agreement and responsiveness of the five dyspnoea scores using different anchors of change.
Anchor: ‘live’ judgment of clinician on improvement
Difference in dyspnoea score Mean (SD) SDC MIC AUC (95%)
Improved Stable
AS 0.9(1.7) -0.1 (1.6) 3.12 0 (0.5) 0.65 (0.61–0.70)
ASS 1.2 (1.8) -0.1 (1.8) 3.53 1 (0.5) 0.70 (0.64–0.75)
CAES-2 1.1 (1.4) 0.1 (1.4) 2.74 0 (0.5) 0.68 (0.61–0.76)
PRAM 1.5 (2.3) 0.0 (2.2) 4.31 0 (0.5) 0.68 (0.62–0.74)
RAD 0.3 (0.7) -0.1 (0.5) 0.98 0 (0.5) 0.65 (0.61–0.70)
Anchor: change in age-equivalent respiratory rate percentiles
Difference in dyspnoea score Mean (SD) SDC MIC AUC (95%)
Improved Stable
AS 1.0 (1.8) 0.4 (1.7) 3.33 1 (0.5) 0.62 (0.55–0.68)
ASS 0.8 (1.7) 0.04 (1.7) 3.33 0 (0.5) 0.63 (0.57–0.68)
CAES-2 0.9 (1.4) 0.2 (1.4) 2.74 0 (0.5) 0.64 (0.57–0.71)
PRAM 1.1 (2.7) 0.3 (2.2) 4.31 1 (0.5) 0.59 (0.51–0.66)
RAD 0.3 (0.7) 0.07 (0.7) 1.37 0 (0.5) 0.62 (0.57–0.67)
SD standard deviation, SDC smallest detectable change; MIC minimal important change; AUC area under curve; AS Asthma score; ASS Asthma severity
score; CAES-2 Clinical asthma evaluation score 2; PRAM Pediatric Respiratory assessment measure; RAD Respiratory rate, accessory muscle use,
decreased breath sounds;
doi:10.1371/journal.pone.0157724.t004
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characteristics of the population examined. In other words, the scores do not seem to be sensi-
tive nor precise enough to detect the often subtle changes in clinical conditions in young chil-
dren. This means that dyspnoea scores should be used with caution. Since none of the scores is
significantly better than the others, it would be preferable if clinicians and researchers in the
field of paediatric pulmonology could agree on which (selection of) dyspnoea scores are to be
used. We would suggest to choose the AS or PRAM since they scored best of all 36 available
dyspnoea scores.
Because the large degree of interrater variation limits the validity of these dyspnoea scores in
children, efforts to diminish this interrater variation are clearly needed. In the absence of studies
examining this, we propose repeated training and discussions over videotaped dyspnoeic patients
between the health care professionals. In addition, objective measures to assess severity of dyspnoea
in young children are needed. Until such more reliable methods become available, health care pro-
fessionals caring for acutely dyspnoeic children need to be aware of the unreliability of these scores.
This implies that repetitive assessment of dyspnoeic children patients should preferably be done by
the same professional, and simultaneous assessment during handovers is warranted.
Strengths and weaknesses
The main strength of our study is the prospective design, with a sufficient number of patients
and observers to enable thorough external validation of different dyspnoea scores simulta-
neously. This has not been done previously. Furthermore the choice to include patients
Table 5. Inter and intrarater reliability and internal consistency of the five dyspnoea scores.
Overall Difference in
score¶
Intrarater reliability Interrater reliability Internal consistency
Score Mean SD SDpool Mean SDdiff ICC (95% CI) SEM ICC (95% CI) SEM Cronbach’s α
AS 7.78 1.91 1.87 0.057 1.36 0.75 (0.71–0.79) 0.96 0.64 (0.56–0.71) 1.12 0.53
ASS 4.61 1.85 1.91 0.018 1.34 0.74 (0.69–0.79) 0.95 0.48 (0.37–0.60) 1.15 0.48
CAES-2 1.82 1.44 1.61 0.022 1.18 0.69 (0.62–0.76) 0.83 0.31 (0.20–0.44) 0.97 0.43
PRAM 3.28 2.31 2.19 0.084 1.91 0.65 (0.59–0.71) 1.35 0.39 (0.27–0.51) 1.31 0.49
Weighted kappa* (95% CI) Weighted kappa* (95% CI) Cronbach’s α
RAD 0.59 (0.51–0.65) 0.32 (0.17–0.53) 0.25
SD standard deviation;SEM Standard Error of Measurement; SDpool pooled SD of the mean scores of the different observers using the formula:p
(SD2observer1 + SD2observer2 + . . ./n) [16, 17]; SDdiff SD of the differences between the two raters [16, 17]; ICC intraclass correlation coefﬁcient; CI
conﬁdence interval; AS Asthma score; ASS Asthma severity score; CAES-2 Clinical asthma evaluation score 2; PRAM Pediatric Respiratory assessment
measure; RAD Respiratory rate, accessory muscle use, decreased breath sounds
¶Difference in the dyspnoea score between the two assessments of the same video by the same rater
*Weighted kappa for ordinal scales, multirater (Light)
doi:10.1371/journal.pone.0157724.t005
Table 6. Floor and ceiling scores and percentages in five dyspnoea scores.
Score Lowest score N (%) Highest score N (%) Sum (%)
AS 5 68 (6.1) 12 21 (1.9) 89 (8.0)
ASS 0 0 (0.0) 9 0 (0.0) 0 (0.0)
CAES-2 0 160 (14.3) 8 2 (0.2) 162 (14.5)
PRAM 0 125 (11.2) 12 0 (0.0) 125 (11.5)
RAD 0 21 (1.9) 3 124 (11.1) 145 (13.0)
AS Asthma score; ASS Asthma severity score; CAES-2 Clinical asthma evaluation score 2; RAD Respiratory rate, accessory muscle use, decreased breath
sounds
doi:10.1371/journal.pone.0157724.t006
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presenting to the hospital with acute dyspnoea without a specific diagnosis increases the gener-
alizability and applicability of our results, because this patient selection closely reflects daily
practice. We used protocolled care for children presenting with acute asthma, pneumonia and
bronchiolitis, with clear treatment and admission criteria, although we cannot deny variance in
practice between physicians and individualized treatments exist.
The limitations of our study are mainly related to the use of audio-visual recordings and the
exclusion of auscultation. The use of videos has its shortcomings in comparison to ‘live’ assess-
ment, because the lack of direct personal contact between patients and caregivers. Nevertheless,
video assessment was the most suitable option enabling us to make comparison among multi-
ple clinicians. We left out auscultation because it was difficult to capture with video recordings.
This might have led to a score that is different than it would be if auscultation was included.
However, previous studies underscored the weak association between auscultatory findings
and the actual degree of airway obstruction [2, 18]. Another limitation of our study is that
most of our patients were moderately dyspnoeic, not representing the entire range of dyspnoea
severity. This may have limited the discriminative power of the scores. However, because severe
dyspnoea accounts for only 1–2% of the population we believe that used dyspnoea scores
should be especially reliable in moderately dyspnoeic children.
We are aware of the central role of the attending pediatrician in this study. The pediatrician
was involved in the clinical decision making with regard to for instance oxygen supplementa-
tion and admission to the hospital. However, the aim of the dyspnoea scores is to reflect clinical
decision making of clinicians and therefore by comparing the dyspnoea scores to precise these
measures seems the most adequate manner to evaluate the applicability of these scores. Fur-
thermore by using several hypotheses without involvement of the attending physician, and by
using a second more objective comparison as an anchor (i.e. respiratory rate) we tried to opti-
mize study design and compensate for a lack of a “true gold standard.
Table 7. Summary of assessed quality criteria for the five dyspnoea scores bases on this study and earlier review by Bekhof et al.[9].
AS ASS CAES-2 PRAM RAD
Validity
Face + + + + +
Content - - - + +
Construct + - - + +
Concurrent - - - - -
Reliability
Agreement - - - - -
Inter observer ± - - - -
Intra observer + + ± ± ±
Internal consistency - - - - -
Responsiveness - ± - - -
Utility
Suitability ± + + + +
Age span + + + + -
Ease of scoring + ± + ± +
Auscultation skills ± ± ± ± ±
Floor and ceiling + + + + +
Total score 7.5 6.5 6 7.5 7
AS Asthma score; ASS Asthma severity score; CAES-2 Clinical asthma evaluation score 2; RAD Respiratory rate, accessory muscle use, decreased breath
sounds;—evaluated and negatively rated, ± evaluated but intermediately positive, + evaluated and positively rated
doi:10.1371/journal.pone.0157724.t007
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Conclusion
This study is the first to prospectively compare the external validity of five different paediatric
dyspnoea scores and enables us to make suggestions about which is the best applicable across
the population of dyspnoeic children. We found that all of the scores have poor measurement
properties, leading to insufficient validity and reliability. Even the two scores with the best test
results (AS and PRAM) lack sufficient discriminative and evaluative power to allow for the sole
use as outcome measure for dyspnoea severity in children.
Supporting Information
S1 File. Overview of tested dyspnoea scores.
(PDF)
S2 File. Quality criteria for measurement properties of paediatric dyspnoea scores.
(PDF)
S3 File. Calculation of minimal important change for the five dyspnoea scores.
(PDF)
S4 File. Original data Dyspnoea scores.
(XLS)
Acknowledgments
Nynke Doorenbos and Ine-Marije Bartels, medical students affiliated with the Princess Amalia
Children’s Clinic, Isala, are gratefully acknowledged for their help in the data acquisition and
discussion of the results.
Author Contributions
Conceived and designed the experiments: JB PB. Performed the experiments: JB RR PB. Ana-
lyzed the data: HE JB. Wrote the paper: HE PB RR JB.
References
1. Bisgaard H, Szefler S. Prevalence of asthma-like symptoms in young children. Pediatr Pulmonol 2007;
42: 723–728. PMID: 17598172
2. Bischop J, Carlin J, Nolan T. Evaluation of the properties and reliability of clinical scoring severity scale
for acute asthma in children. J Clin Epidemiol 1992; 45: 71–76. PMID: 1738014
3. Hurwitz ME, Burney RE, Howatt WE, Crowley D, Mackenzie JR. Clinical scoring does not accurately
assess hypoxemia in pediatric asthma patients. Ann Emerg Med 1984; 13: 1040–1043. PMID:
6486539
4. Kerem E, Canny G, Reisman J, Bentur L, Levison H, Tibshirani R, et al. Clinical-psysiologic correlation
in acute asthma of childhood. Pediatrics 1991; 87:481–486 PMID: 2011424
5. Qureshi F, Pestian J, Davis P, Zaritsky A. Effect of nebulized ipratropium on the hospitalization rates of
children with asthma. N Engl J Med 1998; 339: 1030–1035. PMID: 9761804
6. Zhang L, Mendoza-Sassi R, Santos JC, Lau J. Accuracy of symptoms and signs in predicting hypoxea-
mia among young children with acute respiratory infection: a meta-analysis. Int J Tuberc Lung Dis
2011; 15(3): 317–325. PMID: 21333097
7. Windt van der DAW, Nagelkerke AF, Bouter LM, Dankert-Roelse JE, Veerman AJP. Clinical scores for
acute asthma in pre-school children. A review of the literature. J Clin Epidemiol 1994; 47: 635–646.
PMID: 7722576
8. Birken CS, Parkin PC, Macarthur C. Asthma severity scores for preschoolers displayed weaknesses in
reliability, validity, and responsiveness. J Clin Epidemiol 2004; 57: 1177–1181. PMID: 15567635
9. Bekhof J, Reimink R, Brand PLP. Systematic review: Insufficient validation of clinical scores for the
assessment of acute dyspnea in wheezing children. Pediatr Respirator Rev 2014; 15(1): 98–112
Dyspnoea Scores in Children
PLOS ONE | DOI:10.1371/journal.pone.0157724 July 6, 2016 10 / 11
10. Chalut DS, Ducharme FM, Davis GM. The Preschool Respiratory Assessment Measure (PRAM): a
responsive index of acute asthma severity. J Pediatr 2000; 137: 762–768. PMID: 11113831
11. Ducharme FM, Chalut D, Plotnick L, Savdie C, Kudirka D, Zhang X, et al. The Pediatric Respiratory
Assessment Measure: a valid clinical score for assessing acute asthma severity from toddlers to teen-
agers. J Pediatr 2008; 152: 476–480. doi: 10.1016/j.jpeds.2007.08.034 PMID: 18346499
12. Arnold DH, Gebretsadik T, Abramo TJ, Moons KG, Sheller JR, Hartert TV. The RAD score: a simple
acute asthma severity score compares favourably to more complex scores. Ann Allergy Asthma Immu-
nol 2011; 107: 22–28. doi: 10.1016/j.anai.2011.03.011 PMID: 21704881
13. Fleming S, Thompson M, Stevens R, Heneghan C, Plüddemann A, Maconochie I, Tarassenko L, Mant
D. Normal ranges of heart rate and respiratory rate in children from birth to 18 years of age: a systematic
review of observational studies. Lancet 2011; 377: 1011–1018. doi: 10.1016/S0140-6736(10)62226-X
PMID: 21411136
14. Mokkink LB, Terwee VB, Patrick DL, Alonso J, Stratford PW, Knol DL, et al. The COSMIN study
reached international consensus on taxonomy, terminology, and definitions of measurement properties
for health-related patient reported outcomes. J Clin Epidemiol. 2010; 63(7): 737–745. doi: 10.1016/j.
jclinepi.2010.02.006 PMID: 20494804
15. Terwee CB, Bot SD, de Boer MR, van der Windt DA, Knol DL, Dekker J, et al. Quality criteria were pro-
posed for measurement properties of health status questionnaires. J Clin Epidemiol 2007; 60: 34–42.
PMID: 17161752
16. Vet HCW de, Terwee CB, Mokkink LB, Knol DL. Measurement in medicine: a practical guide. Cam-
bridge, Cambridge University Press, 2011.
17. Bekhof J, Reimink R, Bartels I-M, Eggink H, Brand PLP. Large observer variation of clinical assessment
of dyspnoeic wheezing children. Arch Dis Child 2015; 100(7): 649–53. doi: 10.1136/archdischild-2014-
307143 PMID: 25699564
18. Panickar J, Lakhanpaul M, Lambert PC, Kenia P, Stephenson T, Smyth A, et al. Oral prednisolone for
preschool children with acute virus-induced wheezing. N Engl J Med 2009; 360: 329–38. doi: 10.1056/
NEJMoa0804897 PMID: 19164186
Dyspnoea Scores in Children
PLOS ONE | DOI:10.1371/journal.pone.0157724 July 6, 2016 11 / 11
